In Partnership with:
3442 Stories, most recent news story added 1 hour 24 minutes ago
The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market.
TAMPA, FL--(Marketwire - 11/05/09) - Stem Cell Therapy International Inc. (OTC.BB: SCII - News ) and its soon to be subsidiary, Histostem Ltd. of South Korea ("Histostem"), announced that they recently supplied hematopoietic stem cells to The Queen Mary Hospital of the University of Hong Kong, China, for treatment of Leukemia patients. As reported October 29, 2009 in the Korean Medical ...
Transplantation alleviates side effects of radiotherapy in ratsHuman embryonic stem cells could help people with learning and memory deficits after radiation treatment for brain tumors, suggests a new UC Irvine study.Research with rats found that transplanted stem cells restored learning and memory to normal levels four months after radiotherapy.
Title: Stem Cells May Offer Alternative to Lung Transplants Category: Health News Created: 11/6/2009 4:10:00 PM Last Editorial Review: 11/9/2009
Reportlinker.com announces that a new market research report is available in its catalogue.
A year after the state adopted a proposal to expand embryonic stem cell research, state scientists say the voters' will is being defied by pro-life West Michigan lawmakers.
BONITA SPRINGS, Fla. (Ivanhoe Newswire) -- Its been called the next big frontier in medicine, but stem cell treatment is still in its infancy. Some patients say they don't have time to wait for the studies, so they're ready to risk it all on a controversial transplant.
Doctor awarded money to aid in research of cell-repair mechanisms
Title: Stem Cells Repair Acute Lung Injury in Mice Category: Health News Created: 11/5/2009 4:10:00 PM Last Editorial Review: 11/6/2009
SAN ANTONIO----OncoVista Innovative Therapies, Inc. reported today that two of its proprietary products, the AdnaTest™ BreastCancer and AdnaTest EMT1/StemCell, were evaluated in Germany by the Departments of Gynecology and Obstetrics and Internal Medicine at University Hospital Essen, University of Duisburg-Essen and the Department of Gynecology and Obstetrics, University Hospital of Tuebingen.
It has been called the next frontier in medicine. But stem cell treatment is still in its infancy. Some patients say they don't have time to wait for the studies. So they're ready to risk it all on a controversial transplant. They may be putting their health, hopes and bank accounts in danger.
----Diabetic foot ulcers are the primary cause of hospital admissions for diabetics. Foot ulcers that heal improperly are at risk for infection, which can lead to amputation. According to the American Diabetes Association, one in four patients with diabetic foot ulcers will eventually require lower-limb amputation.
Ann Arbor-based Aastrom Biosciences Inc. (Nasdaq: ASTM) reported progress Friday in a wide variety of human trials for its stem-cell-based products, but continued losses for the first quarter of its fiscal year, which ended Sept. 30.
THURSDAY, Nov. 5 (HealthDay News) -- Adult stem cells from bone marrow can prevent acute lung injury in mice, U.S. researchers report. Acute lung injury, which is caused by major inflammation or injury to the lungs, causes about 74,500 deaths each year in the United States.
For the first time, researchers have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
A gene associated with longevity in roundworms and humans has been shown to affect the function of stem cells that generate new neurons in the adult brain, according to researchers at the Stanford University School of Medicine.
Open slideshowAFP/Getty Images/File
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
Open slideshowReuters
